🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the 1-month effects and safety of esketamine combined PRF and sta...
Status
Recruiting
Location
Beijing Tiantan Hospital
Start Date
2025-04-01
Trial ID
NCT06890897
Treatments Being Tested
Almost 30% of painful patients in emergency departments (ED) describe their...
Status
Completed
Location
CHU de NICE
Start Date
2025-05-06
Trial ID
NCT06853041
Treatments Being Tested
To explore the efficacy of a single low dose of esketamine during surgical ...
Status
Completed
Location
Tianjin Medical University General Hospital
Start Date
2024-05-03
Trial ID
NCT06388824
Treatments Being Tested
A prospective, randomized controlled study was conducted to compare the eff...
Status
Unknown
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2022-08-11
Trial ID
NCT05466708
Treatments Being Tested
To explore the application of different administration modes of esketamine ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04-02
Trial ID
NCT05811221
Treatments Being Tested
To explore the effect of a single intravenous injection of esketamine durin...
Status
Not Yet Recruiting
Location
Tianjin Medical University General Hospital
Start Date
2026-05-05
Trial ID
NCT07560722
Treatments Being Tested
Studies have shown that excessive systemic inflammatory response and concom...
Status
Recruiting
Location
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-07-28
Trial ID
NCT04843982
Treatments Being Tested
Adult patients aged 18-80 years old, American Society of Anesthesiologists ...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-11-01
Trial ID
NCT07264556
Treatments Being Tested
Esketamine is an antagonist of N-methyl-d-aspartate (NMDA) receptor differe...
Status
Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2024-05-05
Trial ID
NCT06430645
Treatments Being Tested
This national, multi-center, randomized controlled study, through the study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07063108
Treatments Being Tested